Counterbalancing of TH2-driven allergic airway inflammation by IL-12 does not require IL-10
- 1 March 2001
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 107 (3) , 483-491
- https://doi.org/10.1067/mai.2001.112693
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Endogenous interleukin‐10 suppresses allergen‐induced airway inflammation and nonspecific airway responsivenessClinical and Experimental Allergy, 2000
- Cytokines in asthmaThorax, 1999
- IMMUNOLOGIC BASIS OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESSAnnual Review of Immunology, 1999
- Administration of Interleukin‐12 Prevents Mite Der p 1 Allergen‐IgE Antibody Production and Airway Eosinophil Infiltration in an Animal Model of Airway InflammationScandinavian Journal of Immunology, 1999
- The Toxicology of Interleukin-12: A ReviewToxicologic Pathology, 1999
- THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune ResponsesAnnual Review of Immunology, 1998
- Regulation of the Interleukin (IL)-12R β2 Subunit Expression in Developing T Helper 1 (Th1) and Th2 CellsThe Journal of Experimental Medicine, 1997
- Interleukin-10 Induction by IL-12: A Possible Modulatory Mechanism?Annals of the New York Academy of Sciences, 1996
- Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones.The Journal of Experimental Medicine, 1994
- Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.The Journal of Experimental Medicine, 1993